TISSUE SPECIFIC EFFECTS OF N⁶-(DELTA ²-ISOPENTENYL) ADENOSINE ON THE INCORPORATION OF PRECURSORS INTO NUCLEIC ACIDS AND PROTEIN IN RATS AND MICE = EFFETS SPECIFIQUES DES TISSUS DE LA N⁶-(DELTA ²-ISOPENTENYL) ADENOSINE SUR L'INCORPORATION DES PRECURSEURS DANS LES ACIDES NUCLEIQUES ET LES PROTEINES CHEZ LES RATS ET LES SOURISRUSTUM Y; MIHICH E.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 6; PP. 1315-1320; BIBL. 26REF.Serial Issue

Modulation of fluoropyrimidines by leucovorin : rational and statusRUSTUM, Y. M.Journal of surgical oncology. 1991, pp 116-123, issn 0022-4790, SUP2Article

Développement de nouvelles méthodes en thérapeutique cancérologique: cas particulier de la mise au point de nouvelles chimiothérapies anticancéreuses = The development of new approaches in the treatment of malignant diseases: emphasis on drug development and treatmentsRUSTUM, Y. M.Entretiens du Carla (Les). 1987, Vol 6, pp 129-137Article

Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer : Role of drug sequence and doseSHOUSONG CAO; RUSTUM, Y. M.Cancer research (Baltimore). 2000, Vol 60, Num 14, pp 3717-3721, issn 0008-5472Article

DISTRIBUTION AND METABOLISM OF LIPOSOME-ENCAPSULATED AND FREE-1-BETA -D-ARABINOFURANOSYLCYTOSINE (ARA-C) IN DOG AND MOUSE TISSUESELLENS H; RUSTUM Y; MAYHEW E et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 2; PP. 324-330; BIBL. 2 P.Article

FRIEND LEUKEMIA CELLS: RELATIONSHIP BETWEEN DIFFERENTIATION, CLONOGENICITY AND MALIGNANCY.PREISLER HD; CHRISTOFF G; REESE P et al.1978; CELL DIFFER.; NETHERL.; DA. 1978; VOL. 7; NO 12; PP. 1-10; BIBL. 10 REF.Article

CHARACTERIZATION, TOXICITY AND THERAPEUTIC EFFICACY OF ADRIAMYCIN ENCAPSULATED IN LIPOSOMESOLSON F; MAYHEW E; MASLOW D et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 2; PP. 167-176; BIBL. 22 REF.Article

Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancerSHOUSONG CAO; TROUTT, A. B; RUSTUM, Y. M et al.Cancer research (Baltimore). 1998, Vol 58, Num 8, pp 1695-1699, issn 0008-5472Article

1-β-arabinofuranosylcytosine in therapy of leukemia : preclinical and clinical overviewRUSTUM, Y. M; RAYMAKERS, R. A. P.Pharmacology & therapeutics (Oxford). 1992, Vol 56, Num 3, pp 307-321, issn 0163-7258Article

BIOCHEMICAL CHARACTERISTICS, METABOLISM, AND ANTITUMOR ACTIVITY OF SEVERAL ACETYLATED HEXOSAMINES.BERNACKI RJ; SHARMA M; PORTER NK et al.1977; J. SUPRAMOLEC. STRUCT.; USA; DA. 1977; VOL. 7; NO 2; PP. 235-250; BIBL. 35 REF.Article

1-β-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell responseRIVA, C. M; RUSTUM, Y. M.Cancer research (Baltimore). 1985, Vol 45, Num 12, pp 6244-6249, issn 0008-5472Article

Potential for selective enhancement of the in vivo metabolism of 1-β-D-arabinofuranosylcytosine in rats by thymidine pretreatmentDANHAUSER, L. L; RUSTUM, Y. M.Cancer research (Baltimore). 1985, Vol 45, Num 5, pp 2002-2007, issn 0008-5472Article

New drugs in therapy of colorectal cancer : Preclinical studiesRUSTUM, Y. M; SHOUSONG CAO.Seminars in oncology. 1999, Vol 26, Num 6, pp 612-620, issn 0093-7754Article

Growth slow-down and growth arrest of human colon carcinoma cells HCT-8 in vitro after exposure to 5-fluoro-2'-deoxyuridineMALMBERG, M; SLOCUM, H. K; RUSTUM, Y. M et al.Cell proliferation (Print). 1993, Vol 26, Num 3, pp 291-303, issn 0960-7722Article

5-Ethynyluracil (776C85) : modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinomaSHOUSOUNG CAO; RUSTUM, Y. M; SPECTOR, T et al.Cancer research (Baltimore). 1994, Vol 54, Num 6, pp 1507-1510, issn 0008-5472Article

Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibitionMING-BIAO YIN; RUSTUM, Y. M.Cancer communications (New York, NY). 1991, Vol 3, Num 2, pp 45-51, issn 0955-3541, 7 p.Article

A model for mimicking the pharmacokinetics of chemotherapy drugs for evaluation of drug effects in a soft agar colony formation assay systemMALMBERG, M; SLOCUM, H. K; RUSTUM, Y. M et al.Selective cancer therapeutics. 1991, Vol 7, Num 4, pp 159-164, issn 1043-0733Article

Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemiaBAER, M. R; BERNSTEIN, S. H; FAY, J. W et al.Blood. 1996, Vol 87, Num 4, pp 1484-1494, issn 0006-4971Article

Glucose consumption end point in primary histoculture indicates recovery of human tumors from drug treatmentSUNG-GOO CHANG; SLOCUM, H. K; TOTH, K et al.In vitro cellular & developmental biology. 1992, Vol 28, Num 9-10, pp 585-587, issn 0883-8364Article

Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growthSCHIRMACHER, P; HELD, W. A; CHISARI, F. V et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2549-2556, issn 0008-5472Conference Paper

Resistance to cytosine arabinoside in cells transfected with activated Ha-ras oncogeneRIVA, C; SAID EL KHYARI; RUSTUM, Y et al.Anticancer research. 1995, Vol 15, Num 4, pp 1297-1302, issn 0250-7005Article

Genetic analysis of liver tumorigeneis in SV40 T antigen transgenic mice implies a role for imprinted genesHELD, W. A; PAZIK, J; O'BRIEN, G et al.Cancer research (Baltimore). 1994, Vol 54, Num 24, pp 6489-6495, issn 0008-5472Article

A combination of 5-fluorouracil and thymidine in advanced colorectal carcinomaSTERNBERG, A; PETRELLI, N. J; AV, J et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 3, pp 218-222, issn 0344-5704Article

Role of fluoropyrimidine schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinomaCAO, S; FRANK, C; RUSTUM, Y. M et al.Journal of the National Cancer Institute. 1996, Vol 88, Num 7, pp 430-436, issn 0027-8874Article

Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglytamate levels in HCT-8 cellsZHENG-GANG ZHANG; RUSTUM, Y. M.Cancer research (Baltimore). 1991, Vol 51, Num 13, pp 3476-3481, issn 0008-5472, 6 p.Article